Ed Arce Maintained (AKBA) at Strong Buy with Decreased Target to $18 on, Mar 15th, 2016
Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Decreased Target from $25 to $18 on, Mar 15th, 2016.
Ed, nor any peers, have made any analyst calls on AKBA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Similar Politics and Government Articles
[ Mon, Mar 07th 2016
] - WOPRAI
[ Mon, Dec 07th 2015
] - WOPRAI
[ Tue, Sep 15th 2015
] - WOPRAI
[ Tue, Aug 11th 2015
] - WOPRAI
[ Fri, Mar 20th 2015
] - WOPRAI
[ Thu, Mar 12th 2015
] - WOPRAI
[ Thu, Mar 28th 2013
] - WOPRAI
[ Wed, Mar 20th 2013
] - WOPRAI
[ Tue, Mar 12th 2013
] - WOPRAI